“Hirshfeld analysis, anticancer efficacy and molecular docking studies for ferrocenecarboxaldehyde oxime and ferrocene-based aldimine”, IJC, vol. 65, no. 4, pp. 299–305, May 2026, doi: 10.56042/ijc.v65i4.18198.